Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise Pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 are potent, oral inhibitors with potential best-in-class profiles in RASm solid tumors Pipeline prioritization and workforce restructuring sharpens focus on programs targeting the highest unmet needs and with highest probability of success Priced concurrent $160 million equity offering Erasca to host conference call and webcast Friday, May 17, 2024 at 8:30 am ET SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-...
Erasca Announces Pricing of Underwritten Offering of Common Stock SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an underwritten offering of 86,486,486 shares of its common stock at a price of $1.85 per share. All of the shares to be sold in the offering are to be sold by Erasca. The gross proceeds to Erasca from the offering, before deducting the underwriting dis...
PubMatic to Participate at Upcoming Investor Summit NO-HEADQUARTERS/REDWOOD CITY, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced that members of its management team are scheduled to participate at an upcoming investor summit. Details for the event are as follows: Evercore ISI 3rd Annual Nothing But Net Internet Summit in New York on Wednesday May 29, 2024. About PubMatic PubMatic (Nasdaq: PUBM) is an independent technology company maximizing custome...
Two Directors at M&T Bank Corp sold/sold after exercising options 24,559 shares at between 152.390USD and 153.781USD. The significance rating of the trade was 79/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the...
Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update –Phase 3, HOPE-3 Trial (Cohort A) of CAP-1002 in Duchenne Muscular Dystrophy Fully Enrolled; On Track to Report Top-Line Data in Q4 2024– –Positive Type-B CMC FDA Meeting held in Q1; Company Aligned with FDA on Demonstration of Non-Clinical Comparability, A Major Milestone on Path to CMC Clearance for BLA– –Received First Milestone Payment of $10 Million under U.S. Distribution and Commercialization Agreement with Nippon Shinyaku in Q1– –Recent FDA Feedback Supports Requests for a Pre-BLA Mee...
LONDON--(BUSINESS WIRE)-- Northern Trust has been appointed by Nest as the new fund administrator, helping the pension scheme coordinate its investments across its diversified portfolio. Through the newly awarded contract, Northern Trust will provide key services for Nest’s investment strategy, including custody, asset allocation and rebalancing, and performance measurement. The new partnership will oversee substantial growth in Nest, with the scheme forecast to pass £100bn AUM in 2030. This contract is therefore of significant importance to the continued success of Nest. Statement from ...
Oxbridge Re Holdings Limited Reports First Quarter 2024 Results GRAND CAYMAN, Cayman Islands, May 09, 2024 (GLOBE NEWSWIRE) -- (), (the “Company”), which together with its subsidiaries is engaged in the business of tokenized Real-World Assets (“RWAs”), initially in the form of tokenized reinsurance securities and reinsurance solutions primarily to property and casualty insurers, today reported its results for the three months ended March 31, 2024. “We were pleased with our core operational performance in the first quarter of 2024 in our Web-3 and reinsurance tokenization business," co...
Quest Resource Holding Corporation Reports First Quarter 2024 Financial Results Double-Digit Growth in Gross Profit Resulting from Business Expansion and Efficiency Gains Significant New Business Wins and Pipeline Growth Reflect Company’s Strong Value Proposition and Momentum Investor Conference Call & Webcast to be held at 5pm ET on Thursday, May 9, 2024 THE COLONY, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Quest Resource Holding Corporation (NASDAQ: QRHC) (“Quest”), a national leader in environmental waste and recycling services, today announced financial results for the first quarter ...
Capricor Therapeutics to Present Exosome Platform Updates at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting -Preclinical findings show exosome-based therapeutic approach for the treatment of arginase-1 deficiency (ARG1-D)- -Presentation to be featured in an oral session being held on May 9, 2024- SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that an abstract featuring new preclinical data highlighting the ther...
Perma-Fix Reports Financial Results and Provides Business Update for the First Quarter of 2024 ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced financial results and provided a business update for the first quarter ended March 31, 2024. Mark Duff, President and CEO of the Company, commented, “As previously disclosed, our financial performance in the first quarter of 2024 was impacted by a few temporary headwinds. However, we have seen steady improvement heading into the second quarter and anticipate a ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.